{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:08:23Z","timestamp":1773014903558,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":38,"publisher":"Springer New York","isbn-type":[{"value":"9781493937547","type":"print"},{"value":"9781493937561","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3756-1_2","type":"book-chapter","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T07:05:17Z","timestamp":1473404717000},"page":"71-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Review and Literature Mining on Proteostasis Factors and Cancer"],"prefix":"10.1007","author":[{"given":"Ana Sofia","family":"Carvalho","sequence":"first","affiliation":[]},{"given":"Manuel S.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[]},{"given":"Rune","family":"Matthiesen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,9,10]]},"reference":[{"issue":"12","key":"2_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrg3337","volume":"13","author":"D Rebholz-Schuhmann","year":"2012","unstructured":"Rebholz-Schuhmann D, Oellrich A, Hoehndorf R (2012) Text-mining solutions for biomedical research: enabling integrative biology. Nat Rev Genet 13(12):829\u2013839. doi:\n                  10.1038\/nrg3337","journal-title":"Nat Rev Genet"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1146\/annurev.biochem.78.101807.093809","volume":"78","author":"RJ Deshaies","year":"2009","unstructured":"Deshaies RJ, Joazeiro CA (2009) RING domain E3 ubiquitin ligases. Annu Rev Biochem 78:399\u2013434. doi:\n                  10.1146\/annurev.biochem.78.101807.093809","journal-title":"Annu Rev Biochem"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1146\/annurev.biochem.78.082307.091526","volume":"78","author":"FE Reyes-Turcu","year":"2009","unstructured":"Reyes-Turcu FE, Ventii KH, Wilkinson KD (2009) Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem 78:363\u2013397. doi:\n                  10.1146\/annurev.biochem.78.082307.091526","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"2_CR4","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1096\/fj.09-136259","volume":"24","author":"SJ Wijk van","year":"2010","unstructured":"van Wijk SJ, Timmers HT (2010) The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins. FASEB J 24(4):981\u2013993. doi:\n                  10.1096\/fj.09-136259","journal-title":"FASEB J"},{"issue":"8","key":"2_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1593\/neo.06376","volume":"8","author":"Y Sun","year":"2006","unstructured":"Sun Y (2006) E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia 8(8):645\u2013654. doi:\n                  10.1593\/neo.06376","journal-title":"Neoplasia"},{"issue":"6","key":"2_CR6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/cr.2011.75","volume":"21","author":"Y Liu","year":"2011","unstructured":"Liu Y, Ye Y (2011) Proteostasis regulation at the endoplasmic reticulum: a new perturbation site for targeted cancer therapy. Cell Res 21(6):867\u2013883. doi:\n                  10.1038\/cr.2011.75","journal-title":"Cell Res"},{"issue":"2","key":"2_CR7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1182\/blood-2010-02-269514","volume":"117","author":"P Perez-Galan","year":"2011","unstructured":"Perez-Galan P, Mora-Jensen H, Weniger MA, Shaffer AL 3rd, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P, Raghavachari N, Stetler-Stevenson M, Yuan C, Pittaluga S, Maric I, Dunleavy KM, Wilson WH, Staudt LM, Wiestner A (2011) Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. Blood 117(2):542\u2013552. doi:\n                  10.1182\/blood-2010-02-269514","journal-title":"Blood"},{"issue":"10","key":"2_CR8","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1158\/1078-0432.CCR-06-0170","volume":"12","author":"RC Kane","year":"2006","unstructured":"Kane RC, Farrell AT, Sridhara R, Pazdur R (2006) United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy. Clin Cancer Res 12(10):2955\u20132960. doi:\n                  10.1158\/1078-0432.CCR-06-0170","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2147\/tcrm.2006.2.3.271","volume":"2","author":"A Field-Smith","year":"2006","unstructured":"Field-Smith A, Morgan GJ, Davies FE (2006) Bortezomib (Velcadetrade mark) in the treatment of multiple myeloma. Ther Clin Risk Manag 2(3):271\u2013279","journal-title":"Ther Clin Risk Manag"},{"issue":"42","key":"2_CR10","doi-asserted-by":"publisher","first-page":"31440","DOI":"10.1074\/jbc.M604356200","volume":"281","author":"AM Fribley","year":"2006","unstructured":"Fribley AM, Evenchik B, Zeng Q, Park BK, Guan JY, Zhang H, Hale TJ, Soengas MS, Kaufman RJ, Wang CY (2006) Proteasome inhibitor PS-341 induces apoptosis in cisplatin-resistant squamous cell carcinoma cells by induction of Noxa. J Biol Chem 281(42):31440\u201331447. doi:\n                  10.1074\/jbc.M604356200","journal-title":"J Biol Chem"},{"issue":"12","key":"2_CR11","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1074\/mcp.M113.034363","volume":"13","author":"AS Carvalho","year":"2014","unstructured":"Carvalho AS, Ribeiro H, Voabil P, Penque D, Jensen ON, Molina H, Matthiesen R (2014) Global mass spectrometry and transcriptomics array based drug profiling provides novel insight into glucosamine induced endoplasmic reticulum stress. Mol Cell Proteomics 13(12):3294\u20133307. doi:\n                  10.1074\/mcp.M113.034363","journal-title":"Mol Cell Proteomics"},{"issue":"7","key":"2_CR12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.4161\/cbt.5.7.2971","volume":"5","author":"A Fribley","year":"2006","unstructured":"Fribley A, Wang CY (2006) Proteasome inhibitor induces apoptosis through induction of endoplasmic reticulum stress. Cancer Biol Ther 5(7):745\u2013748","journal-title":"Cancer Biol Ther"},{"issue":"12","key":"2_CR13","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","volume":"107","author":"EA Obeng","year":"2006","unstructured":"Obeng EA, Carlson LM, Gutman DM, Harrington WJ Jr, Lee KP, Boise LH (2006) Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood 107(12):4907\u20134916. doi:\n                  10.1182\/blood-2005-08-3531","journal-title":"Blood"},{"issue":"3","key":"2_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/sj.cdd.4400801","volume":"8","author":"AP MacLaren","year":"2001","unstructured":"MacLaren AP, Chapman RS, Wyllie AH, Watson CJ (2001) p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. Cell Death Differ 8(3):210\u2013218. doi:\n                  10.1038\/sj.cdd.4400801","journal-title":"Cell Death Differ"},{"issue":"11","key":"2_CR15","first-page":"2615","volume":"59","author":"J Adams","year":"1999","unstructured":"Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S, Elliott PJ (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 59(11):2615\u20132622","journal-title":"Cancer Res"},{"issue":"19","key":"2_CR16","doi-asserted-by":"publisher","first-page":"16639","DOI":"10.1074\/jbc.M200360200","volume":"277","author":"T Hideshima","year":"2002","unstructured":"Hideshima T, Chauhan D, Richardson P, Mitsiades C, Mitsiades N, Hayashi T, Munshi N, Dang L, Castro A, Palombella V, Adams J, Anderson KC (2002) NF-kappa B as a therapeutic target in multiple myeloma. J Biol Chem 277(19):16639\u201316647. doi:\n                  10.1074\/jbc.M200360200","journal-title":"J Biol Chem"},{"issue":"12","key":"2_CR17","doi-asserted-by":"publisher","first-page":"7445","DOI":"10.1074\/jbc.M708347200","volume":"283","author":"Q Wang","year":"2008","unstructured":"Wang Q, Li L, Ye Y (2008) Inhibition of p97-dependent protein degradation by Eeyarestatin I. J Biol Chem 283(12):7445\u20137454. doi:\n                  10.1074\/jbc.M708347200","journal-title":"J Biol Chem"},{"issue":"2","key":"2_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/iub.300","volume":"62","author":"JJ Sacco","year":"2010","unstructured":"Sacco JJ, Coulson JM, Clague MJ, Urbe S (2010) Emerging roles of deubiquitinases in cancer-associated pathways. IUBMB Life 62(2):140\u2013157. doi:\n                  10.1002\/iub.300","journal-title":"IUBMB Life"},{"issue":"5","key":"2_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/GIM.0b013e3181d38f2f","volume":"12","author":"N Petrucelli","year":"2010","unstructured":"Petrucelli N, Daly MB, Feldman GL (2010) Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. Genet Med 12(5):245\u2013259. doi:\n                  10.1097\/GIM.0b013e3181d38f2f","journal-title":"Genet Med"},{"issue":"6553","key":"2_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/378203a0","volume":"378","author":"R Montes de Oca Luna","year":"1995","unstructured":"Montes de Oca Luna R, Wagner DS, Lozano G (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378(6553):203\u2013206. doi:\n                  10.1038\/378203a0","journal-title":"Nature"},{"issue":"13","key":"2_CR21","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/sj.onc.1203468","volume":"19","author":"S Rozieres de","year":"2000","unstructured":"de Rozieres S, Maya R, Oren M, Lozano G (2000) The loss of mdm2 induces p53-mediated apoptosis. Oncogene 19(13):1691\u20131697. doi:\n                  10.1038\/sj.onc.1203468","journal-title":"Oncogene"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ymeth.2014.11.020","volume":"74","author":"S Pletscher-Frankild","year":"2015","unstructured":"Pletscher-Frankild S, Palleja A, Tsafou K, Binder JX, Jensen LJ (2015) DISEASES: text mining and data integration of disease-gene associations. Methods 74:83\u201389. doi:\n                  10.1016\/j.ymeth.2014.11.020","journal-title":"Methods"},{"issue":"2","key":"2_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","volume":"108","author":"AR Venkitaraman","year":"2002","unstructured":"Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108(2):171\u2013182","journal-title":"Cell"},{"issue":"18","key":"2_CR24","doi-asserted-by":"publisher","first-page":"14537","DOI":"10.1074\/jbc.C000881200","volume":"276","author":"R Hashizume","year":"2001","unstructured":"Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H, Ohta T (2001) The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J Biol Chem 276(18):14537\u201314540. doi:\n                  10.1074\/jbc.C000881200","journal-title":"J Biol Chem"},{"issue":"18","key":"2_CR25","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.cub.2012.07.034","volume":"22","author":"K Sato","year":"2012","unstructured":"Sato K, Sundaramoorthy E, Rajendra E, Hattori H, Jeyasekharan AD, Ayoub N, Schiess R, Aebersold R, Nishikawa H, Sedukhina AS, Wada H, Ohta T, Venkitaraman AR (2012) A DNA-damage selective role for BRCA1 E3 ligase in claspin ubiquitylation, CHK1 activation, and DNA repair. Curr Biol 22(18):1659\u20131666. doi:\n                  10.1016\/j.cub.2012.07.034","journal-title":"Curr Biol"},{"issue":"6630","key":"2_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/387296a0","volume":"387","author":"Y Haupt","year":"1997","unstructured":"Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387(6630):296\u2013299. doi:\n                  10.1038\/387296a0","journal-title":"Nature"},{"issue":"1","key":"2_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0014-5793(97)01480-4","volume":"420","author":"R Honda","year":"1997","unstructured":"Honda R, Tanaka H, Yasuda H (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420(1):25\u201327","journal-title":"FEBS Lett"},{"issue":"6630","key":"2_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/387299a0","volume":"387","author":"MH Kubbutat","year":"1997","unstructured":"Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387(6630):299\u2013303. doi:\n                  10.1038\/387299a0","journal-title":"Nature"},{"issue":"5","key":"2_CR29","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.18632\/oncotarget.1797","volume":"5","author":"V Pant","year":"2014","unstructured":"Pant V, Lozano G (2014) Dissecting the p53-Mdm2 feedback loop in vivo: uncoupling the role in p53 stability and activity. OncoTarget 5(5):1149\u20131156","journal-title":"OncoTarget"},{"issue":"35","key":"2_CR30","doi-asserted-by":"publisher","first-page":"33134","DOI":"10.1074\/jbc.M301264200","volume":"278","author":"I Louria-Hayon","year":"2003","unstructured":"Louria-Hayon I, Grossman T, Sionov RV, Alsheich O, Pandolfi PP, Haupt Y (2003) The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation. J Biol Chem 278(35):33134\u201333141. doi:\n                  10.1074\/jbc.M301264200","journal-title":"J Biol Chem"},{"issue":"15","key":"2_CR31","doi-asserted-by":"publisher","first-page":"8662","DOI":"10.1073\/pnas.161506698","volume":"98","author":"Y Suzuki","year":"2001","unstructured":"Suzuki Y, Nakabayashi Y, Takahashi R (2001) Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci U S A 98(15):8662\u20138667. doi:\n                  10.1073\/pnas.161506698","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"32","key":"2_CR32","doi-asserted-by":"publisher","first-page":"21209","DOI":"10.1074\/jbc.M109.018374","volume":"284","author":"JR Neil","year":"2009","unstructured":"Neil JR, Tian M, Schiemann WP (2009) X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression. J Biol Chem 284(32):21209\u201321217. doi:\n                  10.1074\/jbc.M109.018374","journal-title":"J Biol Chem"},{"issue":"12","key":"2_CR33","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nrm1762","volume":"6","author":"MH Schmidt","year":"2005","unstructured":"Schmidt MH, Dikic I (2005) The Cbl interactome and its functions. Nat Rev Mol Cell Biol 6(12):907\u2013918. doi:\n                  10.1038\/nrm1762","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"2_CR34","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/sj.onc.1207298","volume":"23","author":"M Kim","year":"2004","unstructured":"Kim M, Tezuka T, Tanaka K, Yamamoto T (2004) Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation. Oncogene 23(9):1645\u20131655. doi:\n                  10.1038\/sj.onc.1207298","journal-title":"Oncogene"},{"issue":"5438","key":"2_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.286.5438.309","volume":"286","author":"CA Joazeiro","year":"1999","unstructured":"Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T, Liu YC (1999) The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286(5438):309\u2013312","journal-title":"Science"},{"issue":"16","key":"2_CR36","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1093\/emboj\/19.16.4298","volume":"19","author":"K Tanimoto","year":"2000","unstructured":"Tanimoto K, Makino Y, Pereira T, Poellinger L (2000) Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 19(16):4298\u20134309. doi:\n                  10.1093\/emboj\/19.16.4298","journal-title":"EMBO J"},{"issue":"3","key":"2_CR37","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cell.2007.08.045","volume":"131","author":"J Cheng","year":"2007","unstructured":"Cheng J, Kang X, Zhang S, Yeh ET (2007) SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 131(3):584\u2013595. doi:\n                  10.1016\/j.cell.2007.08.045","journal-title":"Cell"},{"issue":"50","key":"2_CR38","doi-asserted-by":"publisher","first-page":"34921","DOI":"10.1074\/jbc.M114.568543","volume":"289","author":"MS Veena","year":"2014","unstructured":"Veena MS, Wilken R, Zheng JY, Gholkar A, Venkatesan N, Vira D, Ahmed S, Basak SK, Dalgard CL, Ravichandran S, Batra RK, Kasahara N, Elashoff D, Fishbein MC, Whitelegge JP, Torres JZ, Wang MB, Srivatsan ES (2014) p16 Protein and gigaxonin are associated with the ubiquitination of NFkappaB in cisplatin-induced senescence of cancer cells. J Biol Chem 289(50):34921\u201334937. doi:\n                  10.1074\/jbc.M114.568543","journal-title":"J Biol Chem"}],"container-title":["Methods in Molecular Biology","Proteostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3756-1_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T23:55:39Z","timestamp":1558050939000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3756-1_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493937547","9781493937561"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3756-1_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"10 September 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}